



The H. Pylori Screening Panel is a comprehensive diagnostic package designed to evaluate Helicobacter pylori (H. pylori) infection, a bacterial infection of the stomach lining commonly associated with gastritis, peptic ulcers, and other gastrointestinal conditions. The package includes the H. pylori Antigen Detection Test, which identifies bacterial antigens in the stool sample. It also includes the H. pylori Urea Breath Test, which detects active infection by measuring the breakdown of urea by the bacterium. The Urea Breath test is a non-invasive breath test that identifies current (active) H pylori nfection. The test uses stable, non-radioactive carbon-13 (¹³C)-labelled urea, making it safe for adults, children, and pregnant or breastfeeding women, as it involves no exposure to ionizing radiation. The antigen detection and urea breath tests are generally preferred for identifying an active H. pylori infection. The package also includes H. pylori IgG and IgM antibody tests, which assess the body's immune response to the bacterium. Together, these tests provide insights into H. pylori exposure and infection status, helping your doctor determine the need for further evaluation or appropriate treatment based on your symptoms, medical history, and test results.








The Helicobacter Pylori, IgG test detects the presence of IgG antibodies in the blood. These antibodies appear a few weeks after infection and stay for months or even years. Their presence shows past exposure to H. pylori.
Getting tested can help understand the risk of H.pylori-related conditions, such as peptic ulcers or gastric cancer. It also helps monitor treatment response over time, allowing infected individuals to take proactive steps against H.Pylori infection and thus reducing the risk of complications.
Know more about Helicobacter Pylori, IgG
The Helicobacter Pylori, IgM test detects the presence of immunoglobulin M (IgM) antibodies produced by the immune system in response to Helicobacter pylori (H. pylori) infection. H.pylori is a bacterium that can colonize in the stomach lining and is associated with various gastrointestinal conditions, including gastritis, peptic ulcers, and gastric cancer.
By detecting IgM antibodies, this test helps doctors diagnose current H. pylori infection as these are the first antibodies to appear as an immediate response to an infection and typically become undetectable after some time. Therefore, the presence of IgM antibodies in the blood signals an active/ongoing H. pylori infection.
The test results can help individuals and doctors understand the risk of H.pylori-related conditions, such as peptic ulcers or gastric cancer, and guide treatment decisions if infection is detected. This test also helps monitor treatment response over time and allows infected individuals to take proactive steps in managing their gastrointestinal health and reducing the risk of complications.
Know more about Helicobacter Pylori, IgM










